New Partner for the Swiss Cannabis Market
The Swiss pharmaceutical distributor Astrasana has reached a significant agreement. The company has secured exclusive distribution rights for the genetics of the Canadian cannabis producer Green Karat in Switzerland.
This partnership enables Astrasana to bring high-quality plant genetics from Canada to the Swiss market. Green Karat is internationally known for its specialized strains, which are now set to be offered in Switzerland under strict quality standards.
For the Swiss market, this means an expansion of the range of medical cannabis products. As the demand for controlled and certified products continues to grow in Switzerland, this step is intended to improve supply security and quality for patients.
The collaboration between the Canadian producer and the Swiss pharmaceutical company underscores the increasing professionalization of the industry. All activities are being carried out within the framework of applicable Swiss laws and regulatory requirements.
In summary, the cooperation represents an important milestone for Astrasana. The availability of Green Karat genetics could significantly influence the selection of available cannabis products in Swiss pharmacies and specialty stores in the coming months.